President & Chief Executive Officer at ATUM
This person is connected to 118 people.
Chief Commercial Officer at ATUM
Adjunct Associate Professor, Department of Plant Breeding & Genetics at Cornell University - College of Agriculture and Life Sciences
Director, General Counsel & Endowment Trustee at BREATHE CALIFORNIA GOLDEN GATE PUBLIC HEALTH PARTNERSHIP
Chief Information Officer at ATUM
Chief Scientific Officer at ATUM
Former Chief Executive Officer at Technica Corp.
Interim President & Chief Executive Officer at Envia Systems, Inc.
Former Managing Director Investment at Temasek
President & Chief Executive Officer at Barefoot Networks, Inc.
President, Chief Executive Officer & Director at Calysta, Inc.
June 1, 2017
April 10, 2017
December 12, 2016
September 1, 2016
The New York Times
May 14, 2016
Paths to Jeremy Minshull
Connections via Relationship Science
The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.
President & Chief Executive Officer
2003 - Current
ATUM provides bioengineering solutions. It offers an integrated pipeline of solutions for the research community including platforms for protein and vector engineering, products such as expression vectors, fluorescent and chromogenic proteins, cell strains and reagents, as well as gene design, optimization and cloning. The company was founded in 2003 and is headquartered in Newark, CA.
Vice President-Core Technology
Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
At Affymax, our mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.
Our first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. With this approved compound, we plan to establish the company as a supportive partner to physicians and patients
Boards & Committees
Calysta, Inc. provides sustainable industrial products for food and energy security. It develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. Its technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels with cost and performance advantages over current processes. The company was founded in 2011 by Joshua Silverman and is headquartered in Menlo Park, CA.
Calysta Biosystems LLC engages in basic organic chemical manufacturing activities. The company was founded by David McElroy on May 20, 2011 and is headquartered in Menlo Park, CA.
You've reached your 7 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!